WorldPharmaNews
  • Home
  • Business
  • Research
  • Events
  • Regulatory

Bristol-Myers Squibb

Bristol-Myers SquibbBristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.

www.bms.com.

Bristol-Myers Squibb RSS Channel

Filters
List of articles in category Bristol-Myers Squibb
Title Published Date
Bristol-Myers Squibb Foundation announces $6 million in grants 10 June 2012
ORENCIA® (abatacept) demonstrates comparable efficacy to Humira® (adalimumab) 06 June 2012
Bristol-Myers Squibb announces global collaboration with leading academic institutions 29 May 2012
Bristol-Myers Squibb Foundation Announces $15 Million Expansion of Together on Diabetes® to China and India 15 May 2012
Bristol-Myers Squibb and Tsinghua University Enter Strategic Partnership 15 May 2012
Bristol-Myers Squibb delivers a solid first quarter 27 April 2012
Bristol-Myers Squibb and Duke Translational Medicine Institute form strategic relationship 29 February 2012
Bristol-Myers Squibb Foundation Announces Grants Focused on Prevention, Diagnosis and Care of Hepatitis B and Hepatitis C in Asia 19 February 2012
Bristol-Myers Squibb Completes Acquisition of Inhibitex, Inc. 13 February 2012
Sanofi and Bristol-Myers Squibb Collect Damages in Plavix Patent Litigation with Apotex 08 February 2012
Bristol-Myers Squibb delivers solid fourth quarter capping a year highlighted by new product approvals 26 January 2012
Bristol-Myers Squibb Announces Charitable Donation of $6.9 Million to Support Cancer Patients 19 January 2012
Bristol-Myers Squibb to Acquire Inhibitex 08 January 2012
Simcere and Bristol-Myers Squibb Enter Innovative Partnership 14 December 2011
Bristol-Myers Squibb Enters Clinical Collaboration Agreement with Tibotec Pharmaceuticals 04 December 2011
Bristol-Myers Squibb Foundation's Together on Diabetes® Initiative Marks First Anniversary 14 November 2011
ASLAN Pharmaceuticals and Bristol-Myers Squibb Enter Innovative Partnership 03 November 2011
Bristol-Myers Squibb Delivers Strong Third Quarter 28 October 2011
Bristol-Myers Squibb Announces Changes in Senior Management Team 20 October 2011
Bristol-Myers Squibb Foundation Announces Collaboration with World Health Organization's Stop TB Department 11 October 2011
  • Start
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • Next
  • End

Business & Industry

  • Novartis shares Zolgensma long-term data demonstrating sustained durability up to 7.5 years post-dosing; 100% achievement of all assessed milestones in children treated prior to SMA symptom onset
  • CPHI Pharma Awards open to global innovators, scientists, entrepreneurs and social leaders
  • Insilico Medicine brings AI-powered "ChatPandaGPT" to its target discovery platform
  • BlueRock Therapeutics to incorporate wearable and invisible contactless digital health technologies from Rune Labs and Emerald Innovations in Parkinson's disease clinical trial
  • Novartis Tafinlar + Mekinist approved by FDA for pediatric patients with BRAF V600E low-grade glioma

Research & Development

  • Candidate found to inhibit malignant melanoma growth
  • A nasal spray protects against coronavirus infection - Effective also against recent immune-evasive variants
  • 'Biohybrid' device could restore function in paralysed limbs
  • Scientists use tardigrade proteins for human health breakthrough
  • DNA treatment could delay paralysis that strikes nearly all patients with ALS
  • Scientists reveal a potential new approach to treating liver cancer
  • Normalizing tumor blood vessels may improve immunotherapy against brain cancer

Conferences & Events

  • SAE Media Group proudly presents the 4th Annual AI in Drug Discovery Conference
  • SAE Media Group's 6th annual 3D Cell Culture Conference
  • CPHI Frankfurt returns to pre-pandemic strength as pharma industry booms again
  • 14th Annual RNA Therapeutics: Investigating the next generation of genetic medicine through RNA based therapies
  • CPHI Excellence in Pharma Award Winners 2022
  • CPHI Frankfurt Report predicts huge funding overhang to drive contract services growth
  • CPHI Frankfurt 2022: Global pharma confidence hits record high in the annual CPHI Pharma Index

Regulatory Affairs

  • FDA approves first over-the-counter naloxone nasal spray
  • FDA grants Accelerated Approval for Alzheimer's disease treatment
  • FDA approves new HIV drug for adults with limited treatment options
  • FDA approves first gene therapy for the treatment of high-risk, non-muscle-invasive bladder cancer
  • FDA approves first gene therapy to treat adults with Hemophilia B
  1. You are here:  
  2. Home
  3. Bristol-Myers Squibb
  4. Bristol-Myers Squibb and Harvard announce new fibrosis research collaboration

About

  • Home
  • Advertise
  • Privacy
  • Cookie Preferences
  • Terms of Use
  • Contact

Top News Channels

  • Industry
  • Research
  • Regulatory

Submit Your News!

Follow / Join us

Didn't we got you connected? If not, please note the following magic buttons:
  • Facebook
  • Twitter
  • LinkedIn
  • XING
  • RSS

Digest World Pharma Newsletter

Subscribe to our weekly Digest Newsletter and stay updated on the latest World Pharma News. Subscribe now, it's free!

© World Pharma News 2023. All Rights Reserved.